Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation

Abstract

Tissue factor (TF) is the main initiator of coagulation and procoagulant phospholipids (PPL) are key components in promoting coagulation activity in blood. Both TF and PPL may be presented on the surface of extracellular vesicles (EVs), thus contributing to their procoagulant activity. These EVs may constitute a substantial part of pathological hypercoagulability that is responsible for triggering a higher risk of thrombosis in certain patients. The aim of this study was to describe a model system for the isolation of EVs required for investigating their effect on coagulation. Differential ultracentrifugation (DUC) with and without a single washing step was used to isolate and evaluate the procoagulant capacity of EVs from healthy volunteers through analysis of thrombin generation and PPL activity. Ultracentrifugation at 20,000 × g and 100,000 × g resulted in pellets containing larger vesicles and smaller vesicles, respectively. Isolation yield of particle concentration was assessed by nanoparticle tracking analysis. Immunoelectron microscopy and western blotting revealed vesicles positive for the commonly used EV-marker CD9. Plasma proteins and lipoproteins were co-isolated with the EVs; however, application of a washing step clearly diminished the amount of contaminants. The isolated EVs were capable of enhancing thrombin generation, mainly due to PPL predominantly present in pellets from 20,000 × g centrifugation, and correlated with the activity measured by a PPL activity assay. Thus, DUC was proficient for the isolation of EVs with minimal contamination from plasma proteins and lipoproteins, and the setup can be used to study EV-associated procoagulant activity. This may be useful in determining the procoagulant activity of EVs in patients at potentially increased risk of developing thrombosis, e.g. cancer patients.Abbreviations: TF: Tissue factor; PL: Phospholipids; EVs: Extracellular vesicles; FXa: Activated coagulation factor X; TGA: Thrombin generation assay; PPL: Procoagulant phospholipids; DUC: Differential ultracentrifugation; NTA: Nanoparticle tracking analysis; TEM: Transmission electron microscopy; SPP: Standard pool plasma; CTI: Corn trypsin inhibitor; 20K: 20,000 × g; 100K: 100,000 × g; FVIII: Coagulation factor VIII

The Potential Role of Extracellular Vesicles in COVID-19 Associated Endothelial injury and Pro-inflammation

“…Together with the vasoconstriction and stagnant blood flow induced by elevated levels of Angiotensin II, inflammation and endothelial injury set the stage for coagulopathy. EVs have been shown to release or present TF and pro-coagulant phospholipids on their surface promoting clot formation and to accelerate fibrin polymerization (32,33). We also found significantly elevated levels of TF, t-PA, and vWF in LEVs from patients with severe COVID-19 compared to healthy controls.…”

Systematic review of extracellular vesicle‐based treatments for lung injury: are EVs a potential therapy for COVID‐19?

“…On the other hand, the intravenous route offers the advantage of being easily reproducible in human patients, as it has already been tested for other types of regenerative medicine compounds, such as stem cells [ 16 ]. However, a potential challenge for EV intravenous administration in COVID-19 patients lies in the reported characteristic of EVs to enhance coagulability [ 100 , 101 ]. Recent reports have indicated that COVID-19 predisposes patients to thrombotic disease, with disseminated coagulation without bleeding, and contributes to poor outcome and prognosis [ 102 – 104 ].…”

Adipose‐Derived Biogenic Nanoparticles for Suppression of Inflammation

“…The clinical translation of EVs and other BiNPs has also been hindered due to inefficient and nonscalable methods of isolation,12–14 such as ultracentrifugation, which is the most commonly used method 15. To overcome the issues faced by conventional isolation techniques, a highly robust, pure, and scalable tangential flow filtration (TFF)‐based method for BiNP isolation was employed 16.…”